Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

MBIO

MindBio Therapeutics (MBIO)

MindBio Therapeutics Corp
De:
Trier par:
 Showing the most relevant articles for your search:CSE:MBIO
DateHeureSourceTitreSymboleSociété
24/08/202315h00InvestorsHub NewsWireMindbio Therapeutics Begins Dosing MB22001 In Phase 2 Clinical Trial In World First Take-home Microdosing Study In Patients With DepressionCSE:MBIOMindBio Therapeutics Corp
14/06/202314h00InvestorsHub NewsWireMindBio Therapeutics Breakthrough Discovery in Microdosing Clinical Trial Reveals Significant Positive Effects on Quality Of SleepCSE:MBIOMindBio Therapeutics Corp
30/05/202314h00InvestorsHub NewsWireMindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at ScaleCSE:MBIOMindBio Therapeutics Corp
23/05/202314h15InvestorsHub NewsWireMindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive DisorderCSE:MBIOMindBio Therapeutics Corp
11/05/202314h29InvestorsHub NewsWireMindBio Therapeutics Phase 2 Clinical Trial Has Received Ethics Approval for World First Take-Home LSD-Microdosing Trials in Cancer Patients Experiencing Emotional DistressCSE:MBIOMindBio Therapeutics Corp
09/05/202315h13InvestorsHub NewsWireMindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy ParticipantsCSE:MBIOMindBio Therapeutics Corp
 Showing the most relevant articles for your search:CSE:MBIO

Dernières Valeurs Consultées

Delayed Upgrade Clock